Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Corey

Showing results (21-30 of 222) with videos related to

Pageof 23
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2018
Tyrosine Kinase Inhibitors Increase MCL1 Degradation and in Combination with BCLXL/BCL2 Inhibitors Drive Prostate Cancer ApoptosisSeiji Arai, Oliver Jonas, Matthew A Whitman, et al.
NPJ Precision Oncology|August 2, 2024
Unveiling novel double-negative prostate cancer subtypes through single-cell RNA sequencing analysisSiyuan Cheng, Lin Li, Yunshin Yeh, et al.
Clinical & Experimental Metastasis|November 13, 2008
Activation of MCP-1/CCR2 axis promotes prostate cancer growth in boneYi Lu, Qiuyan Chen, Eva Corey, et al.
Data in Brief|February 4, 2021
Data of relative mRNA and protein abundances of androgen receptor splice variants in castration-resistant prostate cancerTianfang Ma, Nathan Ungerleider, Derek Y Zhang, et al.
International Journal of Molecular Sciences|September 23, 2022
Oxidation of <i>p</i>-[<sup>125</sup>I]Iodobenzoic Acid and <i>p</i>-[<sup>211</sup>At]Astatobenzoic Acid Derivatives and Evaluation In VivoYawen Li, Ming-Kuan Chyan, Donald K Hamlin, et al.
Scientific Reports|December 18, 2025
CDC7 is a targetable regulator of advanced prostate cancerAlifiani B Hartono, HyeonJi Hwang, Sidharth Paparaju, et al.
The Prostate|November 21, 2015
Addition of PSMA ADC to enzalutamide therapy significantly improves survival in in vivo model of castration resistant prostate cancerVincent A DiPippo, Holly M Nguyen, Lisha G Brown, et al.
The Prostate|June 11, 2009
Nemo-like kinase induces apoptosis and inhibits androgen receptor signaling in prostate cancer cellsKatayoon H Emami, Lisha G Brown, Tiffany E M Pitts, et al.
Cancer Treatment and Research|March 27, 2004
Histological, immunophenotypic and histomorphometric characterization of prostate cancer bone metastasesMartine P Roudier, Eva Corey, Lawrence D True, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2002
Inhibition of androgen-independent growth of prostate cancer xenografts by 17beta-estradiolEva Corey, Janna E Quinn, Mary J Emond, et al.
Pageof 23

Showing results (21-30 of 222) with videos related to

Sort By:
Pageof 23
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2018
Tyrosine Kinase Inhibitors Increase MCL1 Degradation and in Combination with BCLXL/BCL2 Inhibitors Drive Prostate Cancer ApoptosisSeiji Arai, Oliver Jonas, Matthew A Whitman, et al.
NPJ Precision Oncology|August 2, 2024
Unveiling novel double-negative prostate cancer subtypes through single-cell RNA sequencing analysisSiyuan Cheng, Lin Li, Yunshin Yeh, et al.
Clinical & Experimental Metastasis|November 13, 2008
Activation of MCP-1/CCR2 axis promotes prostate cancer growth in boneYi Lu, Qiuyan Chen, Eva Corey, et al.
Data in Brief|February 4, 2021
Data of relative mRNA and protein abundances of androgen receptor splice variants in castration-resistant prostate cancerTianfang Ma, Nathan Ungerleider, Derek Y Zhang, et al.
International Journal of Molecular Sciences|September 23, 2022
Oxidation of <i>p</i>-[<sup>125</sup>I]Iodobenzoic Acid and <i>p</i>-[<sup>211</sup>At]Astatobenzoic Acid Derivatives and Evaluation In VivoYawen Li, Ming-Kuan Chyan, Donald K Hamlin, et al.
Scientific Reports|December 18, 2025
CDC7 is a targetable regulator of advanced prostate cancerAlifiani B Hartono, HyeonJi Hwang, Sidharth Paparaju, et al.
The Prostate|November 21, 2015
Addition of PSMA ADC to enzalutamide therapy significantly improves survival in in vivo model of castration resistant prostate cancerVincent A DiPippo, Holly M Nguyen, Lisha G Brown, et al.
The Prostate|June 11, 2009
Nemo-like kinase induces apoptosis and inhibits androgen receptor signaling in prostate cancer cellsKatayoon H Emami, Lisha G Brown, Tiffany E M Pitts, et al.
Cancer Treatment and Research|March 27, 2004
Histological, immunophenotypic and histomorphometric characterization of prostate cancer bone metastasesMartine P Roudier, Eva Corey, Lawrence D True, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2002
Inhibition of androgen-independent growth of prostate cancer xenografts by 17beta-estradiolEva Corey, Janna E Quinn, Mary J Emond, et al.
Pageof 23